Search Results - "Drozd Højgaard, Lisbeth"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Optimizing an immunomodulatory potency assay for Mesenchymal Stromal Cell by Hansen, Stine Bangsgaard, Højgaard, Lisbeth Drozd, Kastrup, Jens, Ekblond, Annette, Follin, Bjarke, Juhl, Morten

    Published in Frontiers in immunology (12-12-2022)
    “…The expeditious progress of Mesenchymal Stromal Cells (MSC) for therapeutic intervention calls for means to compare differences in potency of cell products…”
    Get full text
    Journal Article
  2. 2

    GMP Compliant Production of a Cryopreserved Adipose-Derived Stromal Cell Product for Feasible and Allogeneic Clinical Use by Haack-Sørensen, Mandana, Johansen, Ellen Mønsted, Højgaard, Lisbeth Drozd, Kastrup, Jens, Ekblond, Annette

    Published in Stem cells international (20-06-2022)
    “…The emerging field of advanced therapy medicinal products (ATMP) holds promise of treating a variety of diseases. Adipose-derived stromal cells (ASCs) are…”
    Get full text
    Journal Article
  3. 3

    Investigating the paracrine and juxtacrine abilities of adipose-derived stromal cells in angiogenesis triple cell co-cultures by Harary Søndergaard, Rebekka, Drozd Højgaard, Lisbeth, Haack-Sørensen, Mandana, Hoeeg, Cecilie, Mønsted Johansen, Ellen, Follin, Bjarke, Kastrup, Jens, Ekblond, Annette, Juhl, Morten

    Published in Stem cell research (01-06-2024)
    “…[Display omitted] •ASCs increase initiation of sprouting equally well in paracrine and juxtacrine triple cell co-cultures.•ASCs surpass the effect of VEGF•ASCs…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Mesenchymal stromal cells to treat patients with non-ischaemic heart failure: Results from SCIENCE II pilot study by Qayyum, Abbas Ali, Frljak, Sabina, Juhl, Morten, Poglajen, Gregor, Zemljičl, Gregor, Cerar, Andraz, Litman, Thomas, Ekblond, Annette, Haack-Sørensen, Mandana, Højgaard, Lisbeth Drozd, Kastrup, Jens, Vrtovec, Bojan

    Published in ESC Heart Failure (22-07-2024)
    “…Allogeneic stem cell therapy is more logistically suitable compared with autologous cell therapy for large-scale patient treatment. We aim to investigate the…”
    Get full text
    Journal Article